FR2856594B1 - Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s) - Google Patents

Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)

Info

Publication number
FR2856594B1
FR2856594B1 FR0307747A FR0307747A FR2856594B1 FR 2856594 B1 FR2856594 B1 FR 2856594B1 FR 0307747 A FR0307747 A FR 0307747A FR 0307747 A FR0307747 A FR 0307747A FR 2856594 B1 FR2856594 B1 FR 2856594B1
Authority
FR
France
Prior art keywords
cosmetic
active
porous particles
pharmaceutical compound
particles charged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0307747A
Other languages
English (en)
French (fr)
Other versions
FR2856594A1 (fr
Inventor
Jean Thierry Simonnet
Bruno Biatry
Leger Didier Saint
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0307747A priority Critical patent/FR2856594B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Priority to EP04300394A priority patent/EP1493433A1/fr
Priority to US10/876,527 priority patent/US20050031699A1/en
Priority to JP2004189843A priority patent/JP4060828B2/ja
Publication of FR2856594A1 publication Critical patent/FR2856594A1/fr
Application granted granted Critical
Publication of FR2856594B1 publication Critical patent/FR2856594B1/fr
Priority to JP2007034350A priority patent/JP5032859B2/ja
Priority to US12/285,297 priority patent/US20090047316A1/en
Priority to JP2010121953A priority patent/JP5273683B2/ja
Priority to US13/311,080 priority patent/US8507006B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0307747A 2003-06-26 2003-06-26 Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s) Expired - Lifetime FR2856594B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0307747A FR2856594B1 (fr) 2003-06-26 2003-06-26 Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)
EP04300394A EP1493433A1 (fr) 2003-06-26 2004-06-23 Particules poreuses chargées en composé(s) actif(s) cosmétique(s) ou pharmaceutique(s)
US10/876,527 US20050031699A1 (en) 2003-06-26 2004-06-28 Porous particles loaded with cosmetically or pharmaceutically active compounds
JP2004189843A JP4060828B2 (ja) 2003-06-26 2004-06-28 化粧料的に又は医薬的に活性な化合物を与えられている多孔性粒子
JP2007034350A JP5032859B2 (ja) 2003-06-26 2007-02-15 化粧料的に又は医薬的に活性な化合物を与えられている多孔性粒子
US12/285,297 US20090047316A1 (en) 2003-06-26 2008-10-01 Porous particles loaded with cosmetically or pharmaceutically active compounds
JP2010121953A JP5273683B2 (ja) 2003-06-26 2010-05-27 化粧料的に又は医薬的に活性な化合物を与えられている多孔性粒子
US13/311,080 US8507006B2 (en) 2003-06-26 2011-12-05 Porous particles loaded with cosmetically or pharmaceutically active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0307747A FR2856594B1 (fr) 2003-06-26 2003-06-26 Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)

Publications (2)

Publication Number Publication Date
FR2856594A1 FR2856594A1 (fr) 2004-12-31
FR2856594B1 true FR2856594B1 (fr) 2006-03-03

Family

ID=33427630

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0307747A Expired - Lifetime FR2856594B1 (fr) 2003-06-26 2003-06-26 Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)

Country Status (3)

Country Link
EP (1) EP1493433A1 (enExample)
JP (3) JP4060828B2 (enExample)
FR (1) FR2856594B1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874321B1 (fr) 2004-08-17 2010-11-26 Oreal Composition topique comprenant des particules poreuses chargees et un compose absorbant le sebum
FR2875134B1 (fr) * 2004-09-16 2007-08-24 Oreal Utilisation cosmetique d'une composition renfermant un derive ascorbique et des particules de polyamide
FR2876284B1 (fr) * 2004-10-08 2007-01-19 Oreal Poudre compacte contenant des particules de polyamide renfermant un actif
WO2006037665A1 (en) * 2004-10-08 2006-04-13 L'oreal Compact powder comprising polyamide particles containing an active agent
FR2892019B1 (fr) * 2005-10-14 2007-11-30 Oreal Procede de traitement des rides et kit de mise en oeuvre
EP1901700A2 (en) * 2005-07-12 2008-03-26 L'Oréal Cosmetic method for the targeting of wrinkles
FR2890310B1 (fr) * 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
FR2924941B1 (fr) * 2007-12-18 2010-01-22 Oreal Procede cosmetique de soin d'une peau ridee
AU2009224418B2 (en) 2008-03-11 2014-12-11 Aska Pharmaceutical Co., Ltd. Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both
FR2930146B1 (fr) * 2008-04-21 2012-05-11 Ab7 Ind Support fibreux comprenant un, ou plusieurs, actif(s) cosmetique(s) microenspherule(s).
KR20160083953A (ko) 2008-09-23 2016-07-12 라보라토리 스킨 케어, 인크. 활성제 장입된 균일하고 강성이면서 구형의 나노다공성 인산칼슘 입자 및 그의 제조 방법과 그의 용도
GB0817936D0 (en) 2008-09-30 2008-11-05 Intrinsiq Materials Global Ltd Porous materials
JP5253974B2 (ja) * 2008-11-14 2013-07-31 株式会社コーセー 多層被覆粒子及びその製造方法並びにそれを含有する皮膚外用剤
WO2010092925A1 (ja) * 2009-02-12 2010-08-19 あすか製薬株式会社 固体分散体とその医薬組成物、並びにそれらの製造方法
FR2944443B1 (fr) * 2009-04-21 2012-11-09 Arkema France Procede de fabrication de particules de poudre libre a base de polyamide impregnee, et particules de poudre libre a base de polyamide ayant une teneur d'au moins 25% en poids d'au moins un agent cosmetique ou pharmaceutique
EP2533753B1 (en) 2009-11-10 2022-07-06 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
WO2011111828A1 (ja) * 2010-03-11 2011-09-15 ライオン株式会社 化粧料組成物
IT1406067B1 (it) * 2010-07-14 2014-02-06 Torino Politecnico Composizioni eudermiche.
FR2966722B1 (fr) * 2010-10-27 2012-11-16 Oreal Composition cosmetique comprenant un alun et des particules poreuses chargees de compose d?acide salicylique
JP2013001685A (ja) * 2011-06-17 2013-01-07 Epia:Kk 鉄粉入り化粧品クリームと、そのスティック
CN107875391A (zh) * 2011-08-16 2018-04-06 实验室护肤股份有限公司 细干颗粒腺苷组合物和包括其的局部制剂
JP6222981B2 (ja) * 2013-05-10 2017-11-01 丸善製薬株式会社 粉末化粧料用粉体および粉末化粧料
FR3019040B1 (fr) * 2014-03-31 2016-03-11 Arkema France Composition cosmetique pour l'eclaircissement de la peau
EP3162762B1 (en) * 2014-06-30 2019-02-27 JGC Catalysts and Chemicals Ltd. Porous silica particles, method for producing same, and cosmetic compounded with same
BR112017008168B1 (pt) * 2014-11-05 2022-08-30 Jgc Catalysts And Chemicals Ltd Partículas de sílica porosa e produto cosmético de limpeza
JP6008997B2 (ja) * 2015-01-08 2016-10-19 ラボラトリー スキン ケア インコーポレイテッド 活性剤を充填した、均一、硬質、球状のナノ多孔質リン酸カルシウム粒子の製造方法
KR101648676B1 (ko) * 2015-03-13 2016-08-16 (주)아모레퍼시픽 다공성 고분자에 무기분체가 함침된 복합분체, 이를 함유하는 화장료 조성물 및 이의 제조방법
WO2019159860A1 (ja) * 2018-02-14 2019-08-22 株式会社 資生堂 香料除去用組成物、消香体および化粧品
JP7198105B2 (ja) * 2018-02-14 2022-12-28 株式会社 資生堂 化粧品

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
JPS62249914A (ja) * 1986-04-22 1987-10-30 Sekisui Plastics Co Ltd 粉末固形状化粧料
FR2600532B1 (fr) * 1986-06-26 1988-08-26 Oreal Utilisation, dans la preparation de poudres pour le maquillage ou les soins du corps ou du visage, d'un materiau synthetique thermoplastique sous la forme de microspheres creuses, et compositions sous forme de poudre non compactee contenant un tel materiau.
FR2619385B1 (fr) * 1987-08-11 1992-01-17 Atochem Poudre de polyamide constituee de particules a structure " rose des sables ". procede d'obtention de la poudre de polyamide
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
LU87429A1 (fr) * 1989-01-17 1990-07-24 Oreal Produit a base de particules de polymere comportant des pigments melaniques,son procede de preparation et son utilisation,en particulier en cosmetique
DE69106226T2 (de) * 1990-06-04 1995-05-11 Tokuyama Corp Basisches Magnesiumkarbonat und Verfahren zu seiner Herstellung.
FR2722102B1 (fr) * 1994-07-11 1996-08-23 Cird Galderma Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
FR2762504B1 (fr) * 1997-04-29 1999-09-10 Cird Galderma Procede d'epilation
KR20010014048A (ko) * 1997-06-20 2001-02-26 마리 케이 인코퍼레이션 미백제와 박피제를 함유한 화장품 조성물
JP2003502435A (ja) * 1999-05-25 2003-01-21 ザ、プロクター、エンド、ギャンブル、カンパニー 軽減された粘着性を有するニコチン酸アミド組成物
AU2001232866A1 (en) * 2000-01-19 2001-07-31 The Procter And Gamble Company Skin care compositions
FR2822376B1 (fr) * 2001-03-23 2004-06-11 Oreal Utilisation de particules de polyamide comme agent anti-irritant dans une composition cosmetique ou dermatologique
KR100845731B1 (ko) * 2001-12-14 2008-07-11 주식회사 코리아나화장품 미백 활성물질을 함유하는 분말형 화장료 조성물
KR100829719B1 (ko) * 2001-12-20 2008-05-15 주식회사 코리아나화장품 주름개선 활성물질을 함유하는 분말형 화장료 조성물
FR2927626B1 (fr) * 2008-02-15 2011-02-25 Arkema France Poudre fine de polyamide issu de matieres renouvelables et procede de fabrication d'une telle poudre.

Also Published As

Publication number Publication date
JP2005047893A (ja) 2005-02-24
JP4060828B2 (ja) 2008-03-12
JP5273683B2 (ja) 2013-08-28
JP5032859B2 (ja) 2012-09-26
FR2856594A1 (fr) 2004-12-31
EP1493433A1 (fr) 2005-01-05
JP2010254698A (ja) 2010-11-11
JP2007161728A (ja) 2007-06-28

Similar Documents

Publication Publication Date Title
FR2856594B1 (fr) Particules poreuses chargees en compose(s) actif(s) cosmetique(s) ou pharmaceutique(s)
DK1660104T3 (da) Farmaceutisk formulering indeholdende lanthanforbindelser
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
IL218698A0 (en) Compounds that inhibit serine protease activity and pharmaceutical compositions containing the same
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
ATE517081T1 (de) Hydroxamsäureester und deren pharmazeutische verwendung
IS7571A (is) Ný lífeðlisfræðilega virk efni
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
EP1645277A4 (en) STABLE FREEZE DRYING MEDICAL TETRODOTOXINE PREPARATION
EP1521589A4 (en) BIOACTIVATION OF PARTICLES
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
DE60328119D1 (de) Pharmazeutische zubereitungen enthaltend modafinil
IL174655A0 (en) Drug containing (2r)-2-propyloctanoic acid as the active ingredient
DE602004014624D1 (de) Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
SE9803272D0 (sv) A drug for cell regeneration
ATE433741T1 (de) Optisch ansprechende kosmetische oder dermatologische zusammensetzung
EP1608330A4 (en) Skin-tightening preparations containing gliadin
SE0102910D0 (sv) New use
DE602004022046D1 (de) Herstellung von kleinen teilchen
EP1581196A4 (en) SÄURELABILE MEDICINAL COMPOSITIONS
FR2857591B1 (fr) Particules comprenant un principe actif sous forme de co-precipite

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20